COMPASS Pathways Overview
- Founded
- 2016
- Status
- Public
- Employees
- 66
- Stock Symbol
- CMPS
- Share Price
- $45.12
- (As of Friday Closing)
COMPASS Pathways General Information
Description
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies, and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Contact Information
Website
Formerly Known As
COMPASS Pathways Technologies
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Therapeutic Devices
Stock Exchange
NAS
Primary Office
- 3rd Floor, 1 Ashley Road
- Cheshire
- Altrincham WA14 2DT
- England, United Kingdom
COMPASS Pathways Timeline
COMPASS Pathways Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $45.12 | $48.21 | $22.51 - $61.69 | $1.62B | 35.9M | 400K | -$4.49 |
COMPASS Pathways Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|
| EV | 1,263,595 | ||
| Revenue | 0 | 0 | 0 |
| EBITDA | (48,883) | (19,534) | (13,197) |
| Net Income | (49,163) | (19,612) | (13,219) |
| Total Assets | 207,995 | 32,389 | 26,386 |
| Total Debt | 0 | 21,089 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
COMPASS Pathways Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore COMPASS Pathways‘s full profile, request access.
Request a free trialCOMPASS Pathways Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore COMPASS Pathways‘s full profile, request access.
Request a free trialCOMPASS Pathways Executive Team (9)
COMPASS Pathways Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Annalisa Jenkins | COMPASS Pathways | Board Member | 000 0000 |
| David Norton | COMPASS Pathways | Board Member | 000 0000 |
| David Norton | COMPASS Pathways | Board Member | 000 0000 |
| Ekaterina Malievskaia MD | COMPASS Pathways | Founder & Board Member | 000 0000 |
| Florian Brand | Self | Board Member | 000 0000 |
COMPASS Pathways Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCOMPASS Pathways Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore COMPASS Pathways‘s full profile, request access.
Request a free trial